The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
vanda pharmaceuticals | 388 |
eli lilly & company | 24 |
vanda pharmeceuticals | 3 |
novartis | 2 |
vanda farmas'jutiklz | 1 |
vanda pharmaceuticals | 38 |
eli lilly & company | 6 |
vanda pharmaceuticals | 52 |
eli lilly & company | 2 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
treatment of circadian rhythm disorders | 66 | 2012 |
metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanami… 🛈 | 33 | 2012 |
melatonin agonist treatment | 29 | 2006 |
cancer treatment | 26 | 2013 |
novel intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluorometh… 🛈 | 26 | 2006 |
an iloperidone metabolite for use in the treatment of psychiatric disorders | 25 | 2012 |
method and composition for treating a serotonin receptor-mediated condition | 24 | 2007 |
method of treatment based on polymorphisms of the kcnq1 gene | 22 | 2009 |
treatment of circadian rhythm disorders | 21 | 2012 |
method and composition for treating an alpha adrenoceptor-mediated condition | 16 | 2007 |